Arteriovenous malformations future or investigational therapies

Jump to navigation Jump to search

Arteriovenous malformations Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Arteriovenous malformations from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Arteriovenous malformations future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Arteriovenous malformations future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Arteriovenous malformations future or investigational therapies

CDC on Arteriovenous malformations future or investigational therapies

Arteriovenous malformations future or investigational therapies in the news

Blogs on Arteriovenous malformations future or investigational therapies

Directions to Hospitals Treating Arteriovenous malformations

Risk calculators and risk factors for Arteriovenous malformations future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Despite many years of research, the central question of whether to treat AVMs has not been answered. All treatments, whether involving surgery, radiation, or drugs, have risks and side-effects. Therefore, it might be better in some cases to avoid treatment altogether and simply accept a small risk of coming to harm from the AVM itself. This question is currently being addressed in clinical trials.[1].

References

Template:WH Template:WS CME Category::Cardiology